Brown-Forman Corporation (BF.A)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	13,561	16,429	22,817	31,327	31,453	35,681
Market Cap Growth	-28.00%	-28.00%	-27.17%	-0.40%	-11.85%	23.83%
Enterprise Value	15,954	18,693	25,634	33,927	32,968	37,234
Last Close Price	28.57	34.33	47.66	63.11	59.10	65.86
PE Ratio	15.61	18.91	22.28	40.01	37.53	39.51
PS Ratio	3.41	4.13	5.46	7.41	8.00	10.31
PB Ratio	3.40	4.11	6.49	9.59	11.49	13.43
P/TBV Ratio	9.00	10.90	21.28	48.42	22.63	29.71
P/FCF Ratio	31.46	38.12	54.46	68.55	39.41	47.26
P/OCF Ratio	22.68	27.47	35.27	48.95	33.60	43.67
EV/Sales Ratio	4.01	4.70	6.14	8.02	8.38	10.76
EV/EBITDA Ratio	12.80	15.00	20.81	26.97	25.07	34.07
EV/EBIT Ratio	13.77	16.13	22.39	28.80	26.67	36.65
EV/FCF Ratio	37.02	43.37	61.18	74.24	41.31	49.32
Debt / Equity Ratio	0.71	0.71	0.91	0.92	0.86	0.99
Debt / EBITDA Ratio	2.20	2.20	2.49	2.31	1.73	2.32
Debt / FCF Ratio	6.58	6.58	7.63	6.56	2.94	3.48
Asset Turnover	0.49	0.49	0.52	0.60	0.61	0.56
Inventory Turnover	0.64	0.64	0.68	0.85	0.86	0.80
Quick Ratio	1.18	1.18	0.78	1.13	1.63	2.07
Current Ratio	3.88	3.88	2.59	3.51	3.65	4.27
Return on Equity (ROE)	23.14%	23.14%	30.18%	26.08%	31.08%	39.00%
Return on Assets (ROA)	8.91%	8.91%	8.98%	10.41%	11.98%	10.33%
Return on Capital (ROIC)	10.70%	10.70%	11.03%	12.98%	14.91%	12.81%
Return on Capital Employed (ROCE)	16.50%	16.50%	17.30%	17.60%	23.20%	18.10%
Earnings Yield	6.41%	5.29%	4.49%	2.50%	2.66%	2.53%
FCF Yield	3.18%	2.62%	1.84%	1.46%	2.54%	2.12%
Dividend Yield	3.17%	2.59%	1.78%	1.25%	1.24%	1.07%
Payout Ratio	49.28%	48.33%	39.45%	48.28%	99.17%	37.43%
Buyback Yield / Dilution	0.90%	0.90%	0.68%	0.02%	0.02%	-0.06%
Total Shareholder Return	4.07%	3.48%	2.45%	1.27%	1.27%	1.02%

Updated Jun 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q